Medical Economics February 25, 2025
Key Takeaways
- Automated insulin delivery technology, like the iLet Bionic Pancreas, significantly improves glycemic control in Type 1 diabetes patients.
- Training by primary care providers or via telehealth is as effective as in-person specialist training for AID technology.
- The study suggests expanding diabetes care access, especially in areas lacking endocrinologists, by utilizing PCPs and telehealth.
- A planned 12-week follow-up study aims to confirm these findings and explore the role of PCPs in diabetes management further.
Study finds that patients see the same results from advanced insulin delivery technology from primary care, telehealth training as they would from in-person specialists.
A study published Monday in Clinical Diabetes found that patients with Type 1 diabetes can achieve significant glycemic improvements...